Chinese Antiserum Maker Secures Government Order in Ethiopia as Profit Falls 22%
Jiangxi Institute of Biological Products has secured government tender orders in Ethiopia as the Chinese antiserum maker expands overseas sales, even as its adjusted net profit fell 21.7 percent in the first half of 2026. The company, listed in Hong Kong as Jiangxi Bio, said it won government tender orders in Ethiopia, Togo and Mongolia...